Indonesia Pharmaceutical Market Outlook to 2022 - Analysis by Therapeutic Segment, Domestic & International Players, Generic & Patent Drugs, OTC & Prescription Drugs and Region

DUBLIN, July 10, 2018 /PRNewswire/ --

The "Indonesia Pharmaceutical Market Outlook to 2022 - By Therapeutic Segment, By Domestic and International Players, By Generic and Patent Drugs, By OTC & Prescription Drugs, By Region" report has been added to ResearchAndMarkets.com's offering.

The report provides information on market size for Indonesia Healthcare and pharmaceutical.

The report covers aspects such as healthcare market segment (by hospitals, pharmaceuticals, medical devices and clinical laboratory), pharmaceutical market segment (by therapeutic segment, by domestic & international players, by generic & patented drug, by OTC & prescription drugs, by domestic sales & exports and by region), competitive landscape of major players in the Indonesia pharmaceutical market, and covering competitive landscape of major pharmaceutical companies.

The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

Key Topics Covered

1. Executive Summary

• Indonesia Healthcare Market Overview
• Indonesia Pharmaceutical Market Segmentation
• Indonesia Pharmaceutical Market Competition Overview
• Indonesia Pharmaceutical Market Future Potential

2. Research Methodology
2.1. Market Definitions
2.2. Abbreviations
2.3. Market Size and Modeling

• Consolidated Research Approach
• Market Sizing - Pharmaceutical Market
• Variables (Dependent and Independent)
• Multi Factor Based Sensitivity Model
• Final Conclusion

3. Indonesia Healthcare Market Size, 2012-2017

4. Indonesia Pharmaceutical Market Introduction
4.1. Indonesia Pharmaceutical Market Size, 2012-2017

5. Indonesia Pharmaceutical Market Segmentation, 2017
5.1. By Therapeutic Segments (Anti-Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others), 2015 & 2017
Vitamins and Dietary Supplements Market, 2012-2017
5.2. By Domestic and International Players, 2012-2017
5.3. By Generic and Patented Drug, 2017
By Type of Generic Drugs (Unbranded, Ethical and Free Sales), 2013 and 2017
5.4. By OTC and Prescription Drugs, 2012-2017
5.5. By Domestic Sales and Exports, 2012-2016
5.6. By Region (West Java, East Java, Central Java, Jakarta and Others), Dec 2016

6. Trends, Developments and Restraint in Indonesia Pharmaceutical Market

• Growth in Indonesia Animal Pharmaceutical and Vaccine Market
• Increased Government Support
• Rise in Mergers and Acquisitions Activities
• Growing Investment from Foreign Companies
• Dependence on Imports for API (Active Pharmaceutical ingredient) Procurement
• Other Challenges Faced

7. Government Regulations for Indonesia Pharmaceutical market

• Pharmaceutical Finished Products Registration Requirement
• Registration Procedure
• Pharmaceutical Raw Materials
• Advertising and Distribution
• FDI in Pharmaceutical Industry
• Procedure of Applying for Patent in Indonesia
• Import Regulations
• Draft Law on Monitoring of Pharmaceutical Supply, Medical Devices and Household Health Products
• Draft law on Hala Product Guarantee
• Regulations for Non-Indonesian Stakeholders Planning to Enter the Pharmaceutical Market

8. Indonesia Biopharmaceutical Industry Snapshot

• Innogene Kalbiotech

9. Snapshot on Indonesia Vaccine Market

10. Competitive Scenario for Major Players in Indonesia Pharmaceutical Market
10.1. Market Share of Major Players in Indonesia Pharmaceutical Market, 2015

11. Competitive Landscape of Major Players in Indonesia Pharmaceutical Market
11.1. PT Kalbe Farma
Product Portfolio for PT Kalbe Farma
11.2. PT Sanbe Farma
Product Portfolio for PT Sanbe Farma
11.3. PT SOHO Global Health
11.4. PT Dexa Medica
Product Portfolio for Dexa Medica
11.5. PT Pharos
Product Portfolio for PT Pharos
11.6. PT Kimia Farma
Product Portfolio for PT Kimia Farma
11.7. PT Tempo Scan Pacific Tbk
Product Portfolio for PT Tempo Scan Pacific Tbk, Indonesia
11.8. PT Merck Tbk
11.9. Overview for Other Major Players (Fahrenheit, Sanofi Aventis, PT. Novell Pharmaceutical Laboratories, Biofarma, Darya Varia and Konimex) in Indonesia Pharmaceutical Market

12. Indonesia Pharmaceutical Market Future Outlook and Projections, 2018-2022
12.1. By Therapeutic Segments (Anti Infectives, Gastrointestinal and Metabolism, Cardiovascular System, Central Nervous System, Respiratory, Musculoskeletal, Dermatology, Genitourinary and Hormones, Blood, Oncology and Others), 2022
12.2. By Generic and Patent Drugs, 2022

13. Analyst Recommendations

14. Macro Economic Factors Affecting Indonesia Healthcare Market
14.1. Population, 2012-2022
14.2. Number of Health Centers, 2012-2022
14.3. Budget Allocation on Healthcare, 2012-2022
14.4. Obese Population, 2012-2022

For more information about this report visit https://www.researchandmarkets.com/research/32l8bn/indonesia?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/indonesia-pharmaceutical-market-outlook-to-2022---analysis-by-therapeutic-segment-domestic--international-players-generic--patent-drugs-otc--prescription-drugs-and-region-300678676.html

SOURCE Research and Markets